We are pleased to present two recent Journal of Hematology & Oncology thematic series:
Aims and scope
Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Read more.
m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."
Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology
Experimental Hematology & Oncology
Submit your research to our companion journal, Experimental Hematology & Oncology
Official journal of
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
- Editorial Board
- Instructions for Editors
- Instructions for authors
- Sign up for article alerts and news from this journal
Annual Journal Metrics
41 days to first decision for reviewed manuscripts only
19 days to first decision for all manuscripts
79 days from submission to acceptance
24 days from acceptance to publication
11.059 - 2-year Impact Factor
8.474 - 5-year Impact Factor
1.923 - Source Normalized Impact per Paper (SNIP)
3.231 - SCImago Journal Rank (SJR)
845 Altmetric Mentions
On the blog
19 February 2021
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).